Outcome Leadership
President and Chief Executive Officer
Richard Gliklich, MD
Dr. Richard Gliklich is President of Outcome, the leading provider for patient registries, studies, and technologies for evaluating real-world outcomes.
Dr. Gliklich focuses on clinical research on the effectiveness, safety, and quality of care. Dr. Gliklich was principal investigator and senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook "Registries for Evaluating Patient Outcomes: A User's Guide." Some of the programs developed by Dr. Gliklich include the American Heart Association's Get With The GuidelinesSM registries in cardiovascular disease, heart failure, and stroke, which involve more than 2,500 U.S. hospital and more than one million patients, and received the 2004 Innovation Award from the U.S. Department of Health and Human Services and the 2007 eHealth Initiative Award.
Dr. Gliklich is a frequently invited speaker on post-approval programs and registries, and has served on numerous advisory boards. He is the director of an annual international conference at Harvard, focusing on post-approval studies, registries, and risk management (Post-Approval Summit®). He has authored more than 90 academic publications, with a large number of articles on patient registries and patient reported outcomes. Dr. Gliklich is the editor of a textbook on the practical value of real-world data in medical practice, "Profiting from Quality: Outcomes strategies for medical practice," published by Jossey-Bass, Inc., in 1999. He is a Principal Investigator (PI) for the Outcome DEcIDE Center, one of 13 DEcIDE centers under the Agency for Healthcare Research and Quality's Effective Healthcare Program. A graduate of Yale University and Harvard Medical School, Dr. Gliklich is also a former Charles A. Dana Scholar at the University of Pennsylvania School of Medicine in outcomes research. In addition to his work at Outcome, Dr. Gliklich is a practicing physician and an Associate Professor at Harvard Medical School.
Chief of Scientific Affairs and Senior Vice President
Nancy Dreyer, MPH, PhD
Nancy Dreyer is Chief of Scientific Affairs and Senior Vice President at Outcome Sciences Inc., a leading provider of strategies and information-based solutions for marketed drugs and medical devices. She leads a team of scientists who design, conduct and interpret observational research on comparative effectiveness and safety, and quality improvement programs.
Dr. Dreyer has more than 25 years of experience in pharmacoepidemiologic research. She trained at the University of North Carolina in Chapel Hill, earning a masters degree and doctorate in Epidemiology. She is a Fellow and Treasurer of the International Society of Pharmacoepidemiology. Her experience includes founding and leading Epidemiology Resources Inc. as CEO, a job she held from the company’s inception through its acquisition 20 years later by UnitedHealth Group. In that role, she also launched and published the peer-reviewed journal, Epidemiology, for its first ten years, and led the New England Epidemiology Institute, an internationally renowned postgraduate summer program operated in collaboration with Tufts Medical School, Boston University School of Public Health, and Erasmus University (The Netherlands). Dr. Dreyer spent 5 years as a senior executive at UnitedHealth Group’s subsidiary, Ingenix/i3 Research, working in clinical trials, epidemiology, and outcomes research. In 2007 Dreyer was recognized by the trade journal Pharmavoice as one of the 100 most inspiring people in the pharmaceutical and life sciences industry.
In addition to her work at Outcome, Dr. Dreyer was a director of the Drug Research Group for 16 years. She is a member of the University of North Carolina School of Public Health Dean’s Advisory Council and also served for 5 years on the Brandeis University Board of Overseers for the Heller School for Social Policy and Management, and as a Consumer Representative in radiopharmaceuticals to the FDA for 4 years.
Her recent accomplishments include serving as a senior editor and co-author of the handbook “Registries for Evaluating Patient Outcomes: A User’s Guide” commissioned and published in 2007 by the U.S. Agency for Healthcare Research and Quality. She also has taken a lead role in developing guidance on Good Research Practices for Observational Studies of Comparative Effectiveness (see www.graceprinciples.org), and, in 2009, was named as a Steering Committee Member for the European Medicines Agency (EMEA)’s PROTECT project for the Innovative Medicines Initiative.
Chief Operating Officer and Senior Vice President
Bob Kaufman, MBA
Bob Kaufman joined Outcome in 2007 as its Chief Operating Officer. He brings more than 25 years of experience in the healthcare industry to the company. Prior to joining Outcome, Bob was the co-founder and Chief Executive Officer of a venture backed healthcare services and technology company, which was successfully sold to a provider of specialized outpatient information solutions and services. He was responsible for overseeing the development of a highly complex technology platform for the capture, reading, and delivery of DICOM images and files to specialty practice based and primary care physicians. Bob has served as the Chief Executive Officer of one of the largest senior housing companies in the United States. He also spent more than 24 years at PriceWaterhouseCoopers, where he was responsible for the service to companies in all segments of the healthcare industry, including advice and consultation in the areas of strategic and long-term planning, operational efficiencies, mergers and acquisitions and corporate restructurings. In addition, Bob served on its Board of Partners, an elected body of partners that was responsible for the oversight and direction of the firm. Bob received his MBA from Cornell University and his BA from Colby College.